180 Life Sciences Corp. (ATNF) Financials
Stock symbol ATNF is outdated, potentially delisted? Maybe it is available on other exchange?
ATNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 3.4 million | 4.4 million |
| Dec. 31, 2023 | 5.3 million | 5.4 million |
| Sept. 30, 2023 | 5.0 million | 5.1 million |
| June 30, 2023 | 13.7 million | 7.0 million |
ATNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | -1.0 million | ? |
| Dec. 31, 2023 | -2.2 million | 501410 |
| Sept. 30, 2023 | -1.8 million | 583994 |
| June 30, 2023 | -3.1 million | 551310 |
ATNF Net Income
No data available :(
ATNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 675977 | - | - |
| Dec. 31, 2023 | 2.0 million | - | - |
| Sept. 30, 2023 | 2.7 million | - | - |
| June 30, 2023 | 2.0 million | - | - |
ATNF Shares Outstanding
ATNF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | - | 535728 | 1.6 million | -23576 |
| Dec. 31, 2023 | - | 36362 | 1.5 million | 22660 |
| Sept. 30, 2023 | - | 1.1 million | 2.4 million | - |
| June 30, 2023 | - | 920904 | 2.8 million | - |
ATNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | - | 23576 |
| Dec. 31, 2023 | 166030 | 22660 |
| Sept. 30, 2023 | - | 32693 |
| June 30, 2023 | - | 28550 |
ATNF
Price: $7.04
52 week price:
Earnings Per Share: -14.95 USD
P/E Ratio: -0.24
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 344800
Market Capitalization: 21.4 million